Resmed Inc Stock Chance of Future Stock Price Finishing Under 83.65

RMD Stock  USD 196.33  2.15  1.11%   
ResMed's implied volatility is one of the determining factors in the pricing options written on ResMed Inc. Implied volatility approximates the future value of ResMed based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in ResMed Inc over a specific time period. For example, 2024-04-19 CALL at $195.0 is a CALL option contract on ResMed's common stock with a strick price of 195.0 expiring on 2024-04-19. The contract was last traded on 2024-03-27 at 14:08:09 for $7.2 and, as of today, has 22 days remaining before the expiration. The option is currently trading at a bid price of $7.3, and an ask price of $7.5. The implied volatility as of the 28th of March is 33.67. View All ResMed options

Closest to current price ResMed long CALL Option Payoff at Expiration

ResMed's future price is the expected price of ResMed instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of ResMed Inc performance during a given time horizon utilizing its historical volatility. Check out ResMed Backtesting, ResMed Valuation, ResMed Correlation, ResMed Hype Analysis, ResMed Volatility, ResMed History as well as ResMed Performance.
  
The current year's Price Earnings To Growth Ratio is expected to grow to 2.95, whereas Price Earnings Ratio is forecasted to decline to 28.14. Please specify ResMed's target price for which you would like ResMed odds to be computed.

ResMed Target Price Odds to finish below 83.65

The tendency of ResMed Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 83.65  or more in 90 days
 196.33 90 days 83.65 
near 1
Based on a normal probability distribution, the odds of ResMed to drop to $ 83.65  or more in 90 days from now is near 1 (This ResMed Inc probability density function shows the probability of ResMed Stock to fall within a particular range of prices over 90 days) . Probability of ResMed Inc price to stay between $ 83.65  and its current price of $196.33 at the end of the 90-day period is over 95.25 .
Considering the 90-day investment horizon the stock has the beta coefficient of 1.63 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, ResMed will likely underperform. Additionally ResMed Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
   ResMed Price Density   
       Price  

Predictive Modules for ResMed

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ResMed Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ResMed's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
194.18196.16198.14
Details
Intrinsic
Valuation
LowRealHigh
178.37180.35215.96
Details
Naive
Forecast
LowNextHigh
187.76189.74191.72
Details
16 Analysts
Consensus
LowTargetHigh
167.44184.00204.24
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as ResMed. Your research has to be compared to or analyzed against ResMed's peers to derive any actionable benefits. When done correctly, ResMed's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in ResMed Inc.

ResMed Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. ResMed is not an exception. The market had few large corrections towards the ResMed's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ResMed Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ResMed within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.01
β
Beta against NYSE Composite1.63
σ
Overall volatility
8.65
Ir
Information ratio 0.03

ResMed Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ResMed for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ResMed Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
About 57.0% of the company shares are owned by institutional investors
On 14th of March 2024 ResMed paid $ 0.48 per share dividend to its current shareholders
Latest headline from fool.com.au: Heres why I think the Resmed share price should be 18 percent higher

ResMed Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ResMed Stock often depends not only on the future outlook of the current and potential ResMed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ResMed's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding147.6 M
Cash And Short Term Investments227.9 M

ResMed Technical Analysis

ResMed's future price can be derived by breaking down and analyzing its technical indicators over time. ResMed Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ResMed Inc. In general, you should focus on analyzing ResMed Stock price patterns and their correlations with different microeconomic environments and drivers.

ResMed Predictive Forecast Models

ResMed's time-series forecasting models is one of many ResMed's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ResMed's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about ResMed Inc

Checking the ongoing alerts about ResMed for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ResMed Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
About 57.0% of the company shares are owned by institutional investors
On 14th of March 2024 ResMed paid $ 0.48 per share dividend to its current shareholders
Latest headline from fool.com.au: Heres why I think the Resmed share price should be 18 percent higher
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:

Complementary Tools for ResMed Stock analysis

When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fundamental Analysis
View fundamental data based on most recent published financial statements
Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.07)
Dividend Share
1.84
Earnings Share
6.04
Revenue Per Share
30.633
Quarterly Revenue Growth
0.125
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.